The Journal of Experimental Medicine
Aegean Conferences: 2009 Conferences
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online September 15, 2008
doi:10.1084/jem.20080809
The Journal of Experimental Medicine, Vol. 205, No. 10, 2251-2268
The Rockefeller University Press, 0022-1007 $30.00
© 2008 Brune et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 4858K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brune, V.
Right arrow Articles by Küppers, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brune, V.
Right arrow Articles by Küppers, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysis

Verena Brune1,2, Enrico Tiacci1, Ines Pfeil1, Claudia Döring2,7, Susan Eckerle2, Carel J.M. van Noesel3, Wolfram Klapper4, Brunangelo Falini5, Anja von Heydebreck6, Dirk Metzler7, Andreas Bräuninger2, Martin-Leo Hansmann2, and Ralf Küppers1

1 Institute for Cell Biology (Tumor Research), University of Duisburg-Essen Medical School, 45122 Essen, Germany
2 Institute for Pathology, University of Frankfurt Medical School, 60590 Frankfurt, Germany
3 Department of Pathology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, Netherlands
4 Institute for Pathology, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany
5 Institute of Hematology, University of Perugia, 06100 Perugia, Italy
6 Bio- and Chemoinformatics, Merck KGaA, 64293 Darmstadt, Germany
7 Institute for Informatics, University of Frankfurt, 60054 Frankfurt, Germany

CORRESPONDENCE Ralf Küppers: ralf.kueppers{at}uk-essen.de

The pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma (NLPHL) and its relationship to other lymphomas are largely unknown. This is partly because of the technical challenge of analyzing its rare neoplastic lymphocytic and histiocytic (L&H) cells, which are dispersed in an abundant nonneoplastic cellular microenvironment. We performed a genome-wide expression study of microdissected L&H lymphoma cells in comparison to normal and other malignant B cells that indicated a relationship of L&H cells to and/or that they originate from germinal center B cells at the transition to memory B cells. L&H cells show a surprisingly high similarity to the tumor cells of T cell–rich B cell lymphoma and classical Hodgkin lymphoma, a partial loss of their B cell phenotype, and deregulation of many apoptosis regulators and putative oncogenes. Importantly, L&H cells are characterized by constitutive nuclear factor {kappa}B activity and aberrant extracellular signal-regulated kinase signaling. Thus, these findings shed new light on the nature of L&H cells, reveal several novel pathogenetic mechanisms in NLPHL, and may help in differential diagnosis and lead to novel therapeutic strategies.


Abbreviations used: BL, Burkitt lymphoma; B-NHL, B cell non-HL; cHL, classical HL; DLBCL, diffuse large B cell lymphoma; ECM, extracellular matrix; ERK, extracellular signal-regulated kinase; FC, fold change; FDR, false discovery rate; FL, follicular lymphoma; GC, germinal center; HL, Hodgkin lymphoma; HRS, Hodgkin and Reed/Sternberg; L&H, lymphocytic and histiocytic; NLPHL, nodular lymphocyte–predominant HL; PCA, principal component analysis; TCRBL, T cell–rich B cell lymphoma; UBD, ubiquitin D.

M.-L. Hansmann and R. Küppers contributed equally to this paper.

I. Pfeil's present address is Institute of Clinical Molecular Biology and Tumor Genetics, Helmholtz Zentrum, 81377 München, Germany.

© 2008 Brune et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS